Latest Regeneration Stories
For the first time, a mouse heart was able to contract and beat again after its own cells were stripped and replaced with human heart precursor cells.
In the new report, the regenerative medicines market for bone and joint applications was valued at $2.72 billion in 2012 and is expected to reach $2.72 billion in 2013.
Neural stem cells proliferate in the subventricular zone and hippocampal dentate gyrus of adult mammals.
If the heart following a heart attack is not sufficiently supplied with blood, heart tissue dies.
“Regenerative Medicines: Bone and Joint Applications” is the new market research report added to ReportsnReports.com store. Dallas, TX (PRWEB) June 26, 2013
- totally perplexed and mixed up.
More Images (2 images) »